BiotechTube
Home/Kiora Pharmaceuticals/Eric J. Daniels, MD, MBA
EJ

Eric J. Daniels, MD, MBA

Chief Development Officer

Kiora Pharmaceuticals

Therapeutic Areas

OphthalmologyRetinal Diseases

Kiora Pharmaceuticals Pipeline

DrugIndicationPhase
KIO-301Retinitis Pigmentosa (Inherited Retinal Disease)Phase 1b
KIO-104Non-infectious UveitisPhase 2

Leadership Team at Kiora Pharmaceuticals

BM
Brian M. Strem, PhD
President & Chief Executive Officer
View full Kiora Pharmaceuticals profile